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Abstract
Liver surgery is still associated with a high rate of morbidity and mortality. We aimed to com-
pare different haemodynamic treatments in liver surgery. In a prospective, blinded, rando-
mised, controlled pilot trial patients undergoing liver resection were randomised to receive
haemodynamic management guided by conventional haemodynamic parameters or by
oesophageal Doppler monitor (ODM, CardioQ-ODM) or by pulse power wave analysis
(PPA, LiDCOrapid) within a goal-directed algorithm adapted for liver surgery. The primary
endpoint was stroke volume index before intra-operative start of liver resection. Secondary
endpoints were the haemodynamic course during surgery and postoperative pain levels.
Due to an unbalance in the extension of the surgical procedures with a high rate of only
minor procedures the conventional group was dropped from the analysis. Eleven patients in
the ODM group and 10 patients in the PPA group were eligible for statistical analysis. Stroke
volume index before start of liver resection was 49 (37; 53) ml/m2 and 48 (41; 56) ml/m2 in
the ODM and PPA group, respectively (p=0.397). The ODM guided group was haemodyna-
mically stable as shown by ODM and PPAmeasurements. However, the PPA guided group
showed a significant increase of pulse-pressure-variability (p=0.002) that was not accompa-
nied by a decline of stroke volume index displayed by the PPA (p=0.556) but indicated by a
decline of stroke volume index by the ODM (p<0.001). The PPA group had significantly
higher postoperative pain levels than the ODM group (p=0.036). In conclusion, goal-directed
optimization by ODM and PPA showed differences in intraoperative cardiovascular parame-
ters indicating that haemodynamic optimization is not consistent between the two monitors.
Trial Registration
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Introduction
The advances in surgical techniques and instruments and the improved knowledge of liver
anatomy have led to a decrease in perioperative morbidity and mortality after liver resections
over the past two decades [1, 2]. However, perioperative morbidity and mortality is still rele-
vant in liver surgery and the amount of intraoperative blood losses and transfused blood units
are key determinants of postoperative morbidity and mortality of patients after liver resections
[3]. From the anesthesiological view, a possibility to reduce intraoperative blood losses is to
guide therapy towards a low central venous pressure (CVP) between 2 to 5 mmHg or below
5 mmHg, especially during parenchymal incision and resection [4–6]. Lowering the CVP is
pathophysiologically based on the mechanism to reduce backflow of blood from the right
atrium through the liver veins to the liver resection area. This approach has been shown to
improve postoperative outcome and reduce hospital length of stay [5–7].
A low CVP is reached by a restrictive intraoperative fluid and volume therapy and the
administration of vasodilatative drugs such as nitroglycerine [6, 8]. The restrictive approach is
based on a very low fixed infusion rate of crystalloid solution and additional fluids guided by
conventional haemodynamic parameters such as arterial blood pressure (ABP), heart rate
(HR) and urine output (UO) [8]. However, this approach entails the risk of occult hypovolae-
mia as conventional haemodynamic parameters are not sensitive enough to detect early hypo-
volaemia and tissue hypoperfusion [9–12]. The misjudgement and a delayed therapy of
hypovolaemia lead to a deteriorated organ function in the postoperative course, [13–15] which
is associated with a prolonged hospital stay, increased costs and higher mortality [16, 17].
An intraoperative goal-directed therapy based on advanced haemodynamic monitoring
could reduce the postoperative morbidity and hospital length of stay in different types of non-
cardiac surgery. In most studies volume therapy was guided to optimize stroke volume based
on the Frank-Starling mechanism [18, 19]. In abdominal surgery, the published haemody-
namic algorithms are aimed at maintaining normovolaemia while in liver surgery this
approach would lead to an increased risk of bleeding especially during parenchymal resection
and result in an increase of postoperative morbidity. Hence, a goal-directed algorithm for liver
surgery needs to be adapted for the demands of liver surgery and should include maintenance
of circulatory flow with a restrictive fluid and volume approach.
Different advanced haemodynamic monitors based on different methods to measure stroke
volume such as ultrasound, pulse power wave analysis or thermodilution could potentially
guide such an algorithm. However, in absence of a gold standard a controversy still exists
about the use of different haemodynamic monitors to guide an intraoperative haemodynamic
management, especially in liver surgery.
Consequently, the aims of the current pilot study were (1) to compare intraoperative hae-
modynamics and the postoperative clinical course in patients undergoing liver resection whose
haemodynamic management was guided by conventional haemodynamic parameters or by
oesophageal Doppler monitor (ODM, CardioQ-ODM) or pulse power wave analysis (PPA,
LiDCOrapid) within a haemodynamic algorithm adapted for liver surgery; (2) to compare the
ODM and PPA in regard to agreement and trending during the course of surgery.
Methods
This was a prospective, single-center, blinded, parallel-group, three-armed randomised con-
trolled trial as a pilot study. Registration of the study was performed internationally (Interna-
tional Standard Randomised Controlled Trial Number Register: ISRCTN64578872, applied
10th March 2009, assigned on 3rd December 2009, principal investigator: Claudia Spies) and
ethical vote was attained from the ethical commission (Ethics Committee of Charité—
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into, or control over, study design, data collection,
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University Medicine Berlin approved on the 22nd January 2009, No. EA 1/004/09). All patients
gave written informed consent. Eligible patients were aged at least 18 years and undergoing
elective liver resection (hemihepatectomy or extended liver resection) at Charité—University
Medicine Berlin, Campus Virchow- Klinikum, Berlin, Germany. Exclusion criteria were age
less than 18 years, pregnancy or lactation, being unable or unwilling to give written consent to
data storage and processing within clinical studies, member of staff of the Charité, simulta-
neous participation in another study, accommodation in an institution due to an official or
judicial order, advanced disease, or operations within the last two months of the oesophagus of
nasopharyngeal cavity, history of bleeding tendency, neurological or psychiatric disease,
unclear history of alcohol related disorder, chronic heart failure class IV according to the New
York Heart Association (NYHA), American Society of Anaesthesiologists (ASA) classification
over III, renal insufficiency with dependency on haemodialysis, pulmonary oedema in the pre-
operative chest X-ray, allergy to gelatine, history of intracranial haemorrhage within one year
before participation in the study before inclusion.
Study design: planning, randomization and blinding
As there were no preliminary data in the literature, describing patients being treated within a
goal-directed haemodynamic algorithm for liver surgery this study was planned as a pilot
study. Before admission to the operating room the patients were randomly assigned to the
study groups in a 1:1:1 ratio for parallel arms according to a randomization list created by a
biostatistician in blocks of six patients with sealed envelopes. The sealed envelopes were in
compulsory order, gave information about the group allocation, had to be filled out and signed
by the study personnel and re-sealed thereafter. There was no stratification used in this study.
The patients were blinded to their allocated study intervention.
Clinical pathway
The patients were evaluated, prepared for the operation and treated according to the published
and certified standards (according to DIN EN ISO 9001) of the Department of Anaesthesiology
and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité
—University Medicine Berlin, Germany.
Study interventions
The patients were randomly assigned to receive intraoperative haemodynamic management
guided by (1) conventional haemodynamic parameters or by (2) oesophageal Doppler monitor
(ODM, CardioQ-ODM) or by (3) pulse power wave analysis (PPA, LiDCOrapid). In each of
the three allocation groups both the ODM and PPA were established.
In the conventional group (1) measurements of the ODM and PPA were performed by the
study personnel while the monitors were blinded to the treating anesthesiological and surgical
team. All haemodynamic treatments in the conventional group were performed according to
the clinical decision of the anaesthetist in charge of the patient. Briefly, the aim was a restrictive
administration of intravenous infusions to lower the CVP towards a value of zero. Based on
conventional haemodynamic parameters such as arterial blood pressure (ABP), norepineph-
rine dosage, heart rate (HR) and urine output (UO) additional fluid and volume administration
was performed to avoid severe tissue hypoperfusion. ABP was maintained by continuous or
bolus administration of norepinephrine.
In the ODM group (2) the CardioQ-ODM was shown to the treating personnel and the
goal-directed algorithm was performed according to the values measured by the ODM, while
blinded measurements of the PPA were performed by study personnel.
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In the PPA group (3) the LiDCOrapid was shown to the treating personnel and the algo-
rithm was performed according to the values measured by the PPA, while blinded measure-
ments of the ODM were performed by study personnel.
Patients
Fifty patients were assessed for eligibility between March 2009 and August 2010. A total of 41
patients were randomly assigned to the study groups.
Two patients in the PPA group and two patients in the conventional group did not receive
the allocated operation as for three patients surgery was cancelled and one patient withdrew
his participation prior to surgery. Two patients in the ODM and one patient in the PPA group
had to be taken out of the intention-to-treat group as the surgical procedure was changed after
laparotomy. In these patients a biliodigestive anastomosis (n = 1), a pylorus-preserving pan-
creaticoduodenectomy (n = 1) and a diagnostic lymphonodectomy (n = 1) were performed.
The conventional group showed a higher number of patients who had to be excluded for
serious reasons (n = 4). In these patients an explorative laparotomy (n = 3) and a diagnostic
lymphonodectomy (n = 1) were performed. Furthermore, there were less extended surgical
procedures in the conventional group. An additional recruitment for patients with more
extended procedures resulted in differences between the additional and randomized controls
and couldn’t settle the unbalance. Therefore, we decided to drop those patients.
In total, 21 patients (ODM group n = 11 and PPA group n = 10) were included in the statis-
tical analysis for primary and secondary endpoints (Fig 1 CONSORT Flow Diagram of the
study).
Haemodynamic protocol and data collection
Haemodynamic management in the ODM and PPA guided group was performed according to
a goal-directed algorithm adapted for liver surgery (Fig 2). This goal-directed algorithm was
developed on the basis of an outcome-based goal-directed haemodynamic algorithm [20]
which was adjusted for the demands of liver surgery.
The goal-directed algorithm guides the administration of intravenous colloid solution to
maintain preload, the titration of norepinephrine to maintain arterial blood pressure and if
necessary the titration of enoximone or nitroglycerine to lower central venous pressure. The
algorithm is divided in three different time periods: (1) the initial preload optimization, (2) the
haemodynamic therapy up to finishing the liver resection, and (3) the preload re-optimization
after sealing the liver resection area.
After induction of anaesthesia and establishing of the advanced haemodynamic monitoring
the haemodynamic algorithm predetermines a fluid challenge with 200ml of a colloid solution
to optimize stroke volume index (SVI). If SVI increases by more than 10% additional fluid
challenges with an intravenous bolus of 200 ml were given until no further increase in stroke
volume of10% could be measured. The value of SVI after the last fluid challenge is defined as
Starting-SVI.
After determining the Starting-SVI the second time period of the haemodynamic algorithm
starts up to the point the liver resection area is surgically sealed. During that period arterial
blood pressure is maintained by titration of continuous administration of norepinephrine to
reach a systolic blood pressure (SBP) of more than 100mmHg and a mean arterial blood pres-
sure (MAP) of more than 65mmHg. If SVI decreases by more than 25% in relation to the Start-
ing-SVI or SVI drops below 40ml/m² a fluid challenge with 200ml of a colloid solution is
performed. At this time, the administration of a fluid challenge is not followed until no further
increase in stroke volume of10% could be measured but instead the volume administration
LiverHaemo
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Fig 1. CONSORT Flow Diagram of the study.
doi:10.1371/journal.pone.0132715.g001
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is stopped if the SVI increased more than 40ml/m² and not lower than 25% of the Starting-SVI.
If there is still central venous congestion measured by an increased central venous pressure
(CVP) and the clinical judgment of venous bleeding during incision of the liver by the surgeon
administration of either enoximone or nitroglycerine could be performed. The indication of a
positive inotrope would be the clinical estimation of the need to lower right ventricular after-
load and to strengthen the myocardial performance. For the titration of nitroglycerine the
Fig 2. Goal-directed haemodynamic algorithm for liver surgery. Haemodynamic algorithm-abbreviations: SVI: stroke volume index [ml/m²], MAP:
mean arterial pressure [mmHg], SBP: systolic blood pressure [mmHg], CVP: central venous pressure [mmHg].Guidelines on the use of the algorithm:
After induction of anaesthesia and implementation of advanced haemodynamic monitoring a fluid challenge with 200ml of a colloid solution is performed. If
stroke SVI increases by more than 10% a further fluid challenge is performed up to the point SVI is not increasing anymore. The value of SVI after the last
fluid challenge is defined as Starting-SVI. After determining the Starting-SVI the second time period of the haemodynamic algorithm starts up to the point the
liver resection area is surgically sealed. During that period arterial blood pressure is maintained by titration of continuous administration of norepinephrine to
reach a systolic blood pressure (SBP) of more than 100mmHg and a mean arterial blood pressure (MAP) of more than 65mmHg. If SVI falls by more than
25% in relation to the Starting-SVI (#) or SVI drops below 40ml/m² a fluid challenge with 200ml of a colloid solution is performed. The performance of a fluid
challenge is not followed up to SVI is not increasing anymore as in published algorithm for preload optimization. Instead the volume administration is stopped
if the SVI is higher than 40ml/m² and not lower than 25% of the Starting-SVI (#). If there is still central venous congestion measured by an increased central
venous pressure (CVP) and the clinical judgment of venous bleeding during incision of the liver by the surgeon administration of either enoximone or
nitroglycerine could be performed (X). After sealing the liver resection area volume administration can once again be guided to optimize SVI according to the
previously published algorithms up to the end of surgery[20].
doi:10.1371/journal.pone.0132715.g002
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indication is the clinical estimation that the patient was previously volume overloaded to
decrease central venous pooling.
After sealing the liver resection area a preload re-optimization is performed again to opti-
mize SVI according to the previously published algorithms up to the end of surgery [20].
During volume administration and haemodynamic data collection there were no changes in
anaesthetic treatment, ventilator settings, dose of norepinephrine or inotropic drugs and
patient positioning. Prior to every optimization period the Doppler probe was readjusted to
ensure an ideal placement. Every 30 minutes zeroing of arterial and central venous pressure
and a fast flush test were performed.
Endpoints
The primary endpoint of this study was stroke volume before the intraoperative start of the
liver resection. Secondary outcome measures were all determined with the study period of 8
postoperative days and included intra- and postoperative haemodynamic parameters, blood
losses, the cumulative frequency of organ dysfunctions (cerebral, pulmonic, renal, abdominal,
cardiovascular), infections, satisfaction of the patients (pain levels), (serious) adverse events
and hospital length of stay and time treated in the intensive care unit.
Statistical Analysis
Because of limited sample sizes and non-normal distributions of the observations, data were
expressed as median [25%, 75% quartiles], or frequencies [%], respectively. For the same rea-
son, differences between the regarded groups in terms of interesting clinical parameters were
univariately tested by using non-parametric exact Mann-Whitney tests for independent groups
or exact Wilcoxon tests for pairwise comparisons within the intervention groups, respectively.
Frequencies were (univariately) tested by the exact Mantel-Haenszel test (ordered categories)
or the exact Chi-square test. Changes in interesting clinical outcomes with respect to time were
analysed using multivariate nonparametric analysis of longitudinal data in a two-factorial
design (1st (independent) factor: groups, 2nd (dependent) factor: repetitions in time). There-
fore, all the time points were simultaneously compared on the corresponding response curves.
The following hypotheses have been tested with those analyses: differences between groups
(over time) [Group], systematic changes in time (over groups) [Time overall], Interactions
between groups and time [Group x Time] as well as systematic changes in time separately for
every group [Time course].
After global testing, post-hoc analyses were carried out to detect specific differences between
groups at fixed times (Mann-Whitney tests) or within groups with respect to interesting pairs
of time points (Wilcoxon tests). A two-tailed p-value< 0.05 was considered statistically signifi-
cant. All tests have to be understood in the area of exploratory data analysis. Therefore, no
adjustments for multiple testing have been made.
Bland-Altman analysis for repeated measurements per patient were used to assess the agree-
ment between ODM and PPA in terms of absolute values of stroke volume during the course
of surgery. The bias was defined as the mean of differences between the two methods. The dif-
ferences were regressed on the average to check for a constant or non-constant bias and vari-
ance. A linear mixed model with random effects was used to adjust for patient times replicate
and method times patient interaction, resulting in a common standard deviation (SD) to calcu-
late the limits of agreement (LOA’s) with upper (mean bias+1.96SD, ULOA) and lower (mean
bias-1.96SD, LLOA) limits [21]. The percentage error (PE) was calculated as [1.96×SD of the
bias/(mean(SVIODM + SVIPPA)/2)] [22]. The limit for an acceptable PE was redefined accord-
ing to the precision of the monitors [23]. The precision of the ODM was previously reported
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ranging from 4.7% to 8.5% [24–26]; because there is no data on the precision of the PPA, we
set the precision of the PPA at 20% [22]. Implying the worst reported precision of the ODM
(8.5%), the redefined PE was therefore determined at< 21.7%.
Trending between ODM and PPA was analysed using the polar plot method [27, 28].
Trending between the two methods is shown by the angle from the polar axis and the magni-
tude of the change in SVI by the distance from the origin. In calculating the polar statistics,
negative changes were converted to positive changes by rotating through 180°; central zone
data (10% changes) were excluded due to intrinsic random error of the measurement of the
ODM and PPA. Subsequently the mean polar angle (or angular bias) and the radial limits of
agreement (RLOA’s, radial sector that contains 95% of the data points) with an upper
(R-ULOA) and lower (R-LLOA) limit were determined. Acceptable trending is generally
defined as an angular bias< ±5° and RLOA’s lying within radial limits of ±30° (boundary lim-
its) [28]. Similar to Bland-Altman analysis the boundary limits for acceptable trending were
adapted according to the precision of both monitors from ±30° to ±21.7° around the angular
bias. The angular concordance rate was calculated as percentage of data points lying within
±21.7° limits.
All numerical calculations were performed with IBM SPSS Statistics, Version 21, Copyright
1989, 2010 SPSS Inc., SAS, Version 9 1, Copyright by SAS Institute, Inc., Cary, NC, USA, and
the R project for Statistical Computing, Version 3.0.1.
Results
Demographic data, baseline characteristics, intraoperative parameters and postoperative out-
come data were not different between the study populations, except that the patients in the
PPA group were significantly younger than in the ODM group (Table 1).
SVI before start of liver resection was SVIODM 49 (37; 53) ml m
-2 in the ODM and SVIPCA
48 (41; 56) ml m-2 in the PPA group, respectively (p = 0.40). In the ODM and PPA group the
patients were haemodynamically stable with respect to arterial blood pressure and heart rate
but in the PPA group there was an increase of norepinephrine levels up to the end of liver inci-
sion and then a decline again (Table 2). In contrast to the ODM group, the central venous pres-
sure dropped in the PPA group during the liver incision (Table 2).
Patients of the ODM group had no decline of stroke volume index during the course of sur-
gery measured by the oesophageal Doppler (p = 0.12) and the LiDCOrapid (p = 0.57). This was
in contrast to the patients of the PPA group. They showed a decline of stroke volume index
measured by the ODM over the time of surgery (p<0.01) while these haemodynamic changes
were not reflected by the measurements of stroke volume index by the LiDCOrapid (p = 0.556)
(Fig 3, 3A1 and 3A2). A drop of the corrected flow time (FTc) measured by the ODM
(p<0.01), a higher stroke volume variability before start of liver incision, an increase of pulse
pressure variability (p<0.01) in the PPA group and higher systemic vascular resistance index
(SVRI) displayed by the ODM further suggest a haemodynamic deterioration throughout the
course of surgery in the PPA group (Table 2, Fig 3B and 3C). Consequently, in the PPA group
stroke volume index, cardiac index and FTc measured by the ODM showed a decrease and
stroke volume variability (SVV) and PPV measured by the LiDCOrapid reflected an increase
over the time course of the operation that was not found in the ODM group. Interestingly,
these haemodynamic differences were not accompanied by differences of the cumulative
administration of the crystalloid or colloid solutions or diuresis (Table 2).
A total of 148 fluid challenges in 21 patients (ODM and PPA group) were performed result-
ing in 296 paired measurements. In regard to absolute values Bland-Altman analysis revealed a
constant bias and variance. ODM and PPA showed a poor agreement resulting in a percentage
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Table 1. General patient characteristics.
Parameter ODM group (n = 11) PPA group (n = 10) P value ODM vs. PPA
Age (years) 69(56;75) 52(41;65) #0.02
Female, n (%) 5 (45.5) 5 (50.0) $1.00
Body Mass Index (kg/m²) 25(23;27) 24(22;29) #0.93
Charlson comorbidity index 6.0(5.0;9.0) 6.0(5.0;9.3) #0.20
Metabolic Equivalent of Task Activity (MET) score 5(4;5) 5(4;5) #1.00
Chronic medications
Beta blocker, n (%) 5(50) 1(11.1) §0.14
ACEI, n (%) 4(40) 2(22.2) §0.63
Statines, n (%) 1(10) 1(11.1) §0.85
Calcium receptor antagonist, n (%) 3(30) 1(11.1) §0.58
Diuretics, n (%) 1(10) 1(11.1) §1.00
Analgetics, n (%) 2(18.2) 0(0) §0.48
Other medications, n (%) 6(60) 6(66.7) §1.00
American Society of Anaesthesiology (ASA) §0.51
ASA Physical Status I, n (%) 1(10) 1(10)
ASA Physical Status II, n (%) 6(60) 3(30)
ASA Physical Status III, n (%) 3(30) 6(60)
Performed surgical procedure §0.82
Segment resection 0(0) 1(10)
Hemihepatectomy 6(54.5) 4(40)
Extended / trisection hepatectomy 5(45.5) 5(50)
Duration of surgery (hh:mm) 04:00(03:20;05:45) 04:57(04:17;05:43) #0.29
Duration of anaesthesia (hh:mm) 05:09(04:53;07:19) 06:23(05:29;07:11) #0.40
Fentanyl (mg) 0.40(0.30;0.65) 0.50(0.29;0.65) #0.99
Remifentanil administration, n (%) 5 (45.5) 7 (70) $0.39
Remifentanil highest Rate (μg/kg/min) 0(0;0.20) 0.20(0;0.28) #0.21
Ketanest administration, n (%) 4 (36.4) 8 (80) $0.08
Administration of piritramide or morphine, (mg morphine equivalents) 5.0(0;5.0) 2.8(0;5.0) #0.30
Clonidin (μg) 0(0;0) 0(0;41) #0.21
Estimated intraoperative blood loss (ml) 720(392;1300) 450(350;975) #0.57
Red packed cells (units per patient) 1.0(0;2.0) 0(0;2.5) #0.64
Fresh frozen plasma (units per patient) 2.0(0;6.0) 2.0(2.0;8.5) #0.53
Patients requiring transfusion during hospital stay, n (%) 9(82) 8(80) $1.00
Patients with complications, n (%) 6 (55) 9 (90) $0.15
Total number of complications per patient (number) [29, 30] 1.0 (0; 2.0) 2.0 (1.0; 3.0) #0.27
Highest grade of complication [29, 30] §0.25
Clavien grade 0, n (%) 5 (46) 1 (10)
Clavien grade I, n (%) 0 (0) 0 (0)
Clavien grade II, n (%) 3 (27) 6 (60)
Clavien grade IIIa, n (%) 2 (18) 2 (20)
Clavien grade IIIb, n (%) 1 (9) 1 (10)
LOS in PACU or HDU (dd/hh) 00:21(00:18;01:03) 00:23(00:20;03:13) #0.25
LOS hospital preoperative (dd:hh) 03:00(01:00;08:00) 02:00(01:18;03:06) #0.45
LOS hospital postoperative (dd:hh) 13:00(12:00;19:00) 13:00(09:18;22:12) #0.91
Hospital discharge within 30 days, n (%) 10(90.9) 9(90) $1.00
Data are shown as median (25%; 75%) quartiles or as number n of patients (%). p-values calculated for the ODM versus the PPA group using the exact
Wilcoxon-Mann-Whitney test #, the exact Mantel-Haenszel test (ordered categories)
§ or the exact Chi-square test
$ as appropriate.
Abreviations: ACEI: angiotensin converting enzyme inhibitor, LOS: length of stay, PACU: postanaesthesia care unit, HDU: high dependency care unit.
doi:10.1371/journal.pone.0132715.t001
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PPA group (n = 10) Non-parametric analysis for longitudinal data ODM
vs. PPA:
Mean arterial pressure (MAP;
mmHg)
T1 68 (61;91) 74 (58;88) Group: 0.46
T2 82 (76;96) 78 (70;86) Time overall: 0.19
T3 75 (69;81) 74 (69;84) Group x Time: 0.55
T4 76 (70;81) 75 (69;82) Time ODM: 0.10
Time PPA: 0.93
Heart rate (HR; beats/min) T1 59 (54;80) 71 (53;84) Group: 0.62
T2 67 (64;88) 72 (66;87) Time overall: 0.04
T3 73 (67;83) 79 (73;108) Group x Time: 0.52
T4 76 (67;87) 74 (65;94) Time ODM: <0.01
Time PPA: 0.12
Norepinephrine (μg kg-1min-1) T1 0(0;0.10) 0.01(0;0.04) Group: 0.25
T2 0.01(0;0.10) 0.04(0.03;0.10) Time overall: <0.01
T3 0.06(0;0.25) 0.15(0.06;0.27) #1 Group x Time: 0.04
T4 0(0;0) 0(0;0) #2#3 Time ODM: <0.01
Time PPA: <0.01
Central venous pressure (CVP;
mmHg)
T1 5 (2;7) 7 (6;11) Group: 0.15
T2 3 (2;5) 2 (1;4) #1 Time overall: <0.01
T3 2 (-1;5) 2 (0;3) #1 Group x Time: 0.74
T4 6 (2;8) 4 (3;8) Time ODM: 0.09
Time PPA: <0.01
Cardiac index (CIODM; l min
-1m-2) T1 2.9(2.2;3.6) 3.8(3.0;5.0) Group: 0.03
T2 3.1(2.4;4.0) 3.0(2.5;3.5) Time overall: <0.01
T3 3.4(2.5;3.9) 2.8(2.3;3.1) #1 Group x Time: 0.44
T4 4.0(3.0;5.0) 4.0(3.0;4.0) #3 Time ODM: 0.02
Time PPA: <0.01
Cardiac index (CILIDCO; l min
-1m-2) T1 2.4(2.2;3.5) 3.6(2.9;4.9) Group: 0.96
T2 3.0(2.3;3.9) 3.3(2.8;4.2) Time overall: 0.41
T3 3.0(2.2;3.9) 3.9(3.0;4.7) Group x Time: 0.37




T1 6(5;9) 7(5;12) Group: 0.20
T2 7(5;12) 12(11;14) * Time overall: 0.56
T3 11(7;15) 11(8;18) Group x Time: 0.17
T4 8(5;12) 12(7;13) Time ODM: 0.31
Time PPA: 0.04
Flow time corrected (FTcODM; ms) T1 361(331;373) 381(372;430) * Group: 0.1
T2 352(338;377) 318(308; 373) Time overall: <0.01
T3 332(302;386) 298(269;343) #1 Group x Time: 0.4
T4 358(332;380) 345(307;377) Time ODM: 0.3
Time PPA: <0.01
Peak velocity (PVODM; cm s
-1) T1 61(53;92) 99(62;127) Group: 0.67
T2 62(57;64) 78(70;109) * Time overall: <0.01
T3 64(58;97) 80(56;104) Group x Time: 0.10
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error of 63.7%. (Fig 4A) Analysing the percentage change of stroke volume during a fluid chal-
lenge Polar Plot analysis revealed a poor trending between ODM and PPA with an angular bias
of -13.7°, radial limits of agreement of -62.2° to 34.7° and an angular concordance rate of 63.5%
(Fig 4B).
Although there were no differences in intraoperatively administered opioids, ketanest or
clonidine patients in the PPA group had higher pain levels even though receiving more mor-
phine equivalents during the postoperative course (Fig 5).
The intraoperative use of the goal-directed haemodynamic algorithm adapted for liver
surgery was feasible and showed high tolerance of the assigned anaesthetists. There were no
surgical complaints of increased bleeding during liver incision and the anaesthetists followed
the algorithm with a very high compliance. The administration of a positive inotrope or nitro-







PPA group (n = 10) Non-parametric analysis for longitudinal data ODM
vs. PPA:
Crystalloid (ml) T1 300(200;600) 175(100;1000) Group: 0.86
T2 1475(800;1600) #1 1200(800;1525) Time overall: <0.01
T3 1700(913;2088) #1 1650(1075;1885) #1 Group x Time: 0.48
T4 1800(1300;2500) #1 2100(1588;2488) #1 Time ODM: <0.01
Time PPA: <0.01
Colloid (ml) T1 0(0;0) 0(0;200) Group: 0.40
T2 600(200;1000) #1 525(350;650) Time overall: <0.01
T3 700(500;1350) #1 625(400;800) #1 Group x Time: 0.41




Crystalloid + Colloid (ml) T1 450(200;600) 425(100;1025) Group: 0.54
T2 1900(1675;2250) #1 1675(1400;1975) Time overall: <0.01







Diuresis (ml) T1 0(0;100) 115(53;163) Group: 0.66
T2 390(80;940) #1 385(148;830) Time overall: <0.01
T3 385(78;1055) #1 390(195;890) #1 Group x Time: 0.40
T4 515(328;1193) #1 590(240;938) #1 Time ODM: <0.01
Time PPA: <0.01
Data are shown as median (25%; 75%) quartiles over the time after start of surgery for the time points: T1 = ﬁrst measurement of advanced
haemodynamic monitoring / start of operation; T2 = before liver resection; T3 = after liver resection; T4 = end of operation. Statistical signiﬁcances: # for
comparisons with respect to time points within the group (exact Wilcoxon tests);
#1: p<0.05 vs. T1,
#2: p<0.05 vs. T2,
#3: p<0.05 vs. T3 and
* for comparisons between the ODM and PPA group (Mann-Whitney tests) with p<0.05 at the time point ODM group vs. PPA group. The nonparametric
analysis for longitudinal data of the parameters between the ODM and the PPA group are outlined with corresponding p values.
doi:10.1371/journal.pone.0132715.t002
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Fig 3. Time course of intraoperative haemodynamic parameters. Time course of stroke volume index
(SVI) of the two intervention groups displayed by ODM (A1) and PPA (A2); time course of pulse pressure
variation (PPV) of the two intervention groups displayed by PPA (B) and systemic vascular resistance index
(SVRI) of the two intervention groups displayed by ODM (C). Data are shown as median (25%; 75%) quartiles
over the time course of surgery and the nonparametric analysis for the parameters that are outlined with
LiverHaemo
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Discussion
The main findings of the study are that (1) within a goal-directed algorithm adapted for liver
surgery the ODM guided group was haemodynamically stable while within the PPA guided
group advanced haemodynamic parameters suggested a potential hypovolaemia which was not
indicated by the course of stroke volume measured by the PPA but reflected by simultaneous
measurements of the ODM, (2) that the PPA guided group had significantly higher postopera-
tive pain levels than the ODM group even though receiving more morphine equivalents during
the postoperative course; and (3) that agreement and trending between ODM and PPA was
poor.
To our knowledge this is the first study comparing the effect of the use of different haemo-
dynamic monitors on the intraoperative haemodynamic parameters within a goal-directed
haemodynamic algorithm in a blinded fashion. The primary endpoint of the study was stroke
volume before liver incision. In regard to univariate analysis SVI at this time point was not sig-
nificantly different between the ODM and the PPA group. However, regarding the time point
after sealing the liver resection area SVI measured by the ODM was significantly higher in the
ODM than in the PPA group but the measurements by the PPA were not different. We found
the same results for the analysis of the time course during the entire course of the operation
with a significant decline of SVI measured by the ODM in the PPA group but no differences in
SVI measured by the PPA in the PPA group. As both monitors do not represent a gold stan-
dard for haemodynamic measurements it is not suitable to state solely by the measurements of
stroke volume that patients were stable or unstable. However, further haemodynamic indica-
tors showed that the patients in the PPA group although being younger had a significant deteri-
oration of norepinephrine levels, a substantial drop of the FTc and an increase of SVV and
PPV during the course of surgery suggesting a potential hypovolaemia. These indicators com-
bined with the discrepancies in SVI measurements might indicate that haemodynamic optimi-
zation by the LiDCOrapid is not comparable to haemodynamic treatment based on the
oesophageal Doppler. This fact could also be clarified by the clinical poor agreement and trend-
ing between ODM and PPA. The poor agreement of the absolute values of stroke volume index
between ODM and PPA is consistent with the results of a recent study evaluating these moni-
tors in colorectal surgery [31]. The poor trending of stroke volume index between the ODM
and the PPA seems to be the substantial issue as therapeutic decisions are based on the ability
to test and confirm patient’s haemodynamic response to appropriately guide haemodynamic
therapy and it supports the fact that haemodynamic therapy based on these monitors might be
different but as none of the monitors represents a gold standard for haemodynamic measure-
ments conclusions of this fact have to be drawn very carefully.
A low CVP of 2 to 5 or below 5mmHg as a target for haemodynamic management in liver
surgery reduces intraoperative blood losses [4–6] and improves postoperative outcome with a
reduced hospital length of stay [5–7]. Due to a higher CVP at the beginning of the operation
there was a significant reduction of the CVP in the PPA and not in the ODM group. However,
in both groups the targeted low CVP was effectively reached by using the algorithm. In the
ODM group a low CVP was reached without a drop of SVI, CI or FTc or an increase in norepi-
nephrine levels, SVV or PPV. This indicates that the haemodynamic management within a
goal-directed haemodynamic algorithm guided by oesophageal Doppler was able to reduce
corresponding p values. Statistical significances: # for comparisons with respect to time points within the
group (exact Wilcoxon tests); #1: p<0.05 vs. T1, #2: p<0.05 vs. T2, #3: p<0.05 vs. T3 and * for comparisons
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Fig 4. Bland-Altman and Polar Plot analysis. Bland-Altman plot for multiple measurements per patient
assessing the agreement between ODM and PPA in terms of absolute values during the course of surgery
(A) and Polar Plot analysis assessing trending of stroke volume during a fluid challenge between ODM and
PPA (B). ULOA—Upper limit of agreement (bias+1.96SD); LLOA—Lower limit of agreement (bias-1.96SD);
PE—percentage error; R-LLOA = Radial lower limit of agreement (bias-1.96SD). The shaded area (defined
by RLOA’s and boundary limits) visualizes the magnitude of non-agreement between ODM and PPA.
doi:10.1371/journal.pone.0132715.g004
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Fig 5. Postoperative pain and administration of morphine. Time course of postoperative pain at rest measured by the Visual Analog Scale (VAS) and the
administered amounts of morphine equivalents (mg). Data are shown as median (25%; 75%) quartiles over the time after the end of surgery and the
nonparametric analysis for the parameters that are outlined with corresponding p values.
doi:10.1371/journal.pone.0132715.g005
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backflow in the liver while maintaining circulatory flow. As this study was not planned to eval-
uate the clinical impact of the use of advanced haemodynamic monitors further studies are
needed to direct this question.
The differences in postoperative pain levels and administrated morphine equivalents could
be an indicator of clinical association of an intraoperative deteriorated haemodynamic status
and the postoperative consequence of increased pain. In acute bleeding in healthy volunteers
[11] a drop of stroke volume was associated with a deteriorated gastric microperfusion and in
chronic heart failure one of the first areas with a reduced perfusion was the upper gastro-
intestinal (GI) region [32]. That is why we think that a reduced blood flow in the surgical area
of the study patients could be a contributor to the development of postoperative pain in upper
GI surgery. This is the first study to our knowledge to show the association of a deviated hae-
modynamic status to postoperative pain and we think this should lead to the point that in
future haemodynamic studies pain should be a secondary outcome measure. However, we can-
not exclude that the differences in pain are associated to the differences of ages between study
groups, but to our knowledge there is no study published showing this relationship.
The adapted goal-directed haemodynamic algorithm to guide volume and catecholamine
administration in liver surgery was feasible and showed a high clinical tolerance. After primary
preload optimization the algorithm could prevent substantial haemodynamic instability
reflected by the current used open monitor up to the sealing of the liver resection area without
any complaints of increased bleeding tendency during liver incision. To our knowledge this is
the first algorithm to guide volume and catecholamine administration by advanced haemody-
namic monitoring measuring circulatory flow in liver surgery.
Goal-directed optimization by the oesophageal Doppler and the LiDCOrapid showed differ-
ences in intraoperative cardiovascular parameters, postoperative pain and opioid administra-
tion. Again, it is not possible to state that one monitor might be wrong and another is better
but it can be stated out of our data that haemodynamic optimization with the oesophageal
Doppler is not the same as with the LiDCOrapid and vice versa. As the recommendations to
perform goal-directed haemodynamic therapy is grossly based on studies using the oesopha-
geal Doppler it seems important to us that based on the results presented here the use of the
LiDCOrapid for goal-directed haemodynamic therapy has to be confirmed in further prospec-
tive randomised controlled studies to confirm its beneficial clinical impact during anaesthesia.
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